JP2018508491A5 - - Google Patents

Download PDF

Info

Publication number
JP2018508491A5
JP2018508491A5 JP2017540129A JP2017540129A JP2018508491A5 JP 2018508491 A5 JP2018508491 A5 JP 2018508491A5 JP 2017540129 A JP2017540129 A JP 2017540129A JP 2017540129 A JP2017540129 A JP 2017540129A JP 2018508491 A5 JP2018508491 A5 JP 2018508491A5
Authority
JP
Japan
Prior art keywords
oeg
γglu
pharmaceutical composition
human insulin
desb30 human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017540129A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018508491A (ja
JP6737793B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/051813 external-priority patent/WO2016119854A1/en
Publication of JP2018508491A publication Critical patent/JP2018508491A/ja
Publication of JP2018508491A5 publication Critical patent/JP2018508491A5/ja
Application granted granted Critical
Publication of JP6737793B2 publication Critical patent/JP6737793B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017540129A 2015-01-29 2015-01-29 錠剤コアとポリビニルアルコールコーティングとを含む経口インスリン投与のための医薬組成物 Expired - Fee Related JP6737793B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2015/051813 WO2016119854A1 (en) 2015-01-29 2015-01-29 Pharmaceutical composition for oral insulin administration comprising a tablet core and a polyvinyl alcohol coating

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020082000A Division JP2020117542A (ja) 2020-05-07 2020-05-07 錠剤コアとポリビニルアルコールコーティングとを含む経口インスリン投与のための医薬組成物

Publications (3)

Publication Number Publication Date
JP2018508491A JP2018508491A (ja) 2018-03-29
JP2018508491A5 true JP2018508491A5 (https=) 2019-10-03
JP6737793B2 JP6737793B2 (ja) 2020-08-12

Family

ID=52462305

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017540129A Expired - Fee Related JP6737793B2 (ja) 2015-01-29 2015-01-29 錠剤コアとポリビニルアルコールコーティングとを含む経口インスリン投与のための医薬組成物

Country Status (5)

Country Link
US (1) US20180000742A1 (https=)
EP (1) EP3250225A1 (https=)
JP (1) JP6737793B2 (https=)
CN (1) CN107206059A (https=)
WO (1) WO2016119854A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10919949B2 (en) 2017-08-17 2021-02-16 Novo Nordisk A/S Acylated insulin analogues and uses thereof
KR20210102347A (ko) 2018-12-11 2021-08-19 사노피 인슐린 수용체 결합 친화성이 감소된 인슐린 유사체
WO2021029467A1 (en) * 2019-08-14 2021-02-18 Sam Chun Dang Pharm. Co., Ltd. A solid dosage form for orally administration
CN118754967A (zh) * 2019-12-30 2024-10-11 甘李药业股份有限公司 胰岛素衍生物
WO2023012263A1 (en) 2021-08-04 2023-02-09 Novo Nordisk A/S Solid oral peptide formulations
JP2025508982A (ja) 2022-03-03 2025-04-10 サイプルメド ゲーエムベーハー 治療用ペプチドおよびタンパク質の改善された経口医薬製剤
TW202421645A (zh) 2022-11-25 2024-06-01 丹麥商諾佛 儂迪克股份有限公司 如ｇｌｐ—１之肽治療劑的口服投與

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935326A (en) * 1967-06-28 1976-01-27 Boehringer Mannheim G.M.B.H. Process for coating tablets with aqueous resin dispersions
GB9414045D0 (en) * 1994-07-12 1994-08-31 Berwind Pharma Service Moisture barrier film coating composition, method, and coated form
SI21402A (sl) * 2003-02-12 2004-08-31 LEK farmacevtska dru�ba d.d. Obloženi delci in farmacevtske oblike
AU2004264958B2 (en) * 2003-08-13 2010-04-15 Biocon, Ltd Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
AR049142A1 (es) * 2004-06-07 2006-06-28 Wyeth Corp Composiciones para recubrimientos de azucar,composiciones recubiertas y metodos para la fabricacion de los mismos
RU2527893C2 (ru) * 2004-07-19 2014-09-10 Биокон Лимитед Инсулин-олигомерные конъюгаты, их препараты и применения
BRPI0710503A2 (pt) * 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
RU2524150C2 (ru) * 2006-09-22 2014-07-27 Ново Нордиск А/С Аналоги инсулина, устойчивые к протеазам
RU2453332C2 (ru) * 2007-10-16 2012-06-20 Байокон Лимитид Твердая фармацевтическая композиция (варианты) и способ контроля концентрации глюкозы с ее помощью, способ получения твердой фармацевтической композиции (варианты), таблетка (варианты) и способ получения амфорных частиц
HUE032284T2 (en) * 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues
AU2010339907A1 (en) * 2009-12-16 2012-07-05 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
CN102335431B (zh) * 2010-07-14 2015-08-26 上海蓝心医药科技有限公司 一种给药组合物及其制备和使用方法
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
KR20130036290A (ko) * 2010-06-23 2013-04-11 노보 노르디스크 에이/에스 추가 이황화 결합을 함유하는 인슐린 유도체
US20140357838A1 (en) * 2011-12-21 2014-12-04 Novo Nordisk A/S N-Terminally Modified Insulin Derivatives
JP2016524617A (ja) * 2013-05-30 2016-08-18 ノヴォ ノルディスク アー／エス 糖尿病の治療のための新規な経口医薬組成物

Similar Documents

Publication Publication Date Title
JP2018508491A5 (https=)
KR101682965B1 (ko) 구강내 붕괴성 피복 정제
HRP20200753T1 (hr) Farmaceutske formulacije koje sadrže dapagliflozin propilen glikol hidrat
HRP20231613T1 (hr) Pripravci koji sadrže sredstvo za unošenje i njihova priprava
JP2015510916A5 (https=)
JP2018184458A5 (https=)
AR094374A1 (es) Composiciones y métodos para el tratamiento de trastornos metabólicos
ES2957495T3 (es) Formulaciones de comprimidos de liberación modificada que contienen inhibidores de fosfodiesterasa
JP2015038135A5 (https=)
JP2014218522A5 (https=)
JP2019516739A5 (https=)
JP2016510326A5 (https=)
IL251413B2 (en) Composition of injectable buprenorphine
PE20130657A1 (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona
AR100977A1 (es) Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación
RU2018137590A (ru) Фармацевтические композиции для производного n-пропаргиламина
JP2015120758A5 (https=)
JP2016538288A5 (https=)
EP3513811A1 (en) Delayed release dosage forms comprising dimethyl fumarate
AU2016231883A1 (en) Pharmaceutical compositions of dimethyl fumarate
AR097202A1 (es) Composiciones farmacéuticas de ranolazina y dronedarona, procedimiento para elaborar tableta bicapa
MX2010013978A (es) Derivados de 5-(4-metanosulfonilfenil)tiazol para el tratamiento de enfermedades inflamatorias agudas y cronicas.
Silva et al. Segregated delivery of rifampicin and isoniazid from fixed dose combination bilayer tablets for the treatment of tuberculosis.
SI2914599T1 (en) The solid salt form as alpha-6-mPEG6-O-hydroxycodone as opioid agonists and its use
RU2017119465A (ru) Фармацевтические композиции, которые содержат лобеглитазон, для перорального введения